[Federal Register Volume 85, Number 95 (Friday, May 15, 2020)]
[Notices]
[Pages 29451-29453]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-10409]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-20-20HP]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled National Evaluation of the DP18-1815
Cooperative Agreement Program: Category B, Cardiovascular Disease
Prevention and Management to the Office of Management and Budget (OMB)
for review and approval. CDC previously published a ``Proposed Data
Collection Submitted for Public Comment and Recommendations'' notice on
July 5, 2019, to obtain comments from the public and affected agencies.
CDC did not receive comments related to the previous notice. This
notice serves to allow an additional 30 days for public and affected
agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary
[[Page 29452]]
for the proper performance of the functions of the agency, including
whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
National Evaluation of the DP18-1815 Cooperative Agreement Program:
Category B, Cardiovascular Disease Prevention and Management--New--
National Center for Chronic Disease Prevention and Health Promotion
(NCCDPHP), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and Prevention (CDC) plans to
conduct a comprehensive evaluation of the recently launched five-year
Cooperative Agreement program CDC-RFA-DP18-1815PPHF18: Improving the
Health of Americans Through Prevention and Management of Diabetes and
Heart Disease and Stroke, hereafter referred to as ``1815''. This
cooperative agreement funds all 50 State Health Departments and the
Washington, DC health department (hereafter referred to as ``HD
recipients'') to support investments in implementing evidence-based
strategies to prevent and manage cardiovascular disease (CVD) and
diabetes in high-burden populations/communities within each state and
the District of Columbia. High burden populations/communities are those
affected disproportionately by high blood pressure, high blood
cholesterol, diabetes, or prediabetes due to socioeconomic or other
characteristics, including access to care, poor quality of care, or low
income. The 1815 program is a collaboration between the Division of
Diabetes Translation (DDT) and the Division of Heart Disease and Stroke
Prevention (DHDSP), and is structured into two program categories
aligning with each Division.
This information collection request focuses on activities conducted
under Category B, Cardiovascular Disease Prevention and Management.
Progress will be assessed for three CVD program areas: (1) Tracking and
monitoring clinical quality measures (CQM) shown to improve healthcare
quality and identify patients with hypertension; (2) Implementing team-
based care and medication therapy management (TBC/MTM) for patients
with high blood pressure and high blood cholesterol; and (3) Fostering
community-clinical linkages (CCL) for community resources and clinical
services that support systematic referrals, self-management, and
lifestyle change for patients with high blood pressure and high blood
cholesterol.
This cooperative agreement is a substantial investment of federal
funds. DDT and DHDSP are responsible for the stewardship of these
funds, and they must be able to demonstrate the types of interventions
being implemented and what is being accomplished through the use of
these funds. Thus, throughout the five-year cooperative agreement
period, CDC will work with HD recipients to track the implementation of
the cooperative agreement strategies and evaluate program processes and
outcomes. In order to collect this information for Category B, CDC has
designed three overarching components: (1) Category B case studies, (2)
Category B cost study, and (3) Category B recipient-led evaluations.
Each component consists of data collection mechanisms and tools that
are designed to capture the most relevant information needed to inform
the evaluation effort while placing minimum burden on respondents.
Respondents will include HD recipients, as well as select HD recipient
partner sites, which are organizations that HD recipients are
partnering with in the implementation of the 1815 strategies.
The evaluation of cooperative agreement strategies and activities
conducted by DHDSP will determine the efficiency, effectiveness, impact
and sustainability of 1815-funded strategies in the promotion,
prevention, and management of diabetes and heart disease and help
identify promising practices that can be replicated and scaled to
better improve health outcomes. In addition, evaluation plays a
critical role in organizational learning, program planning, decision-
making, and measurement of the 1815 strategies. As an action-oriented
process, the evaluation will serve to identify programs that have
positive outcomes, identify those that may need additional technical
assistance support, and highlight the specific activities that make the
biggest contribution to improving diabetes and cardiovascular disease
prevention and management efforts. Without collection of new evaluative
data, CDC will not be able to capture critical information needed to
continuously improve programmatic efforts and clearly demonstrate the
use of federal funds.
OMB approval is requested for three years. Participation is
required for cooperative agreement awardees and voluntary for partner
sites. The total estimated annualized burden hours are 743.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondent Form name respondents responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
Health Department (1815 Recipient).... CQM Health Department 17 1 1.5
Interview Guide.
CQM Group Discussion 27 1 2
Guide.
TBC Health Department 9 1 1.5
Interview Guide.
[[Page 29453]]
MTM Health Department 8 1 1.5
Interview Guide.
TBC Group Discussion 27 1 2
Guide.
CCL Health Department 17 1 1.5
Interview Guide.
CCL Group Discussion 27 1 2
Guide.
Cost Study Resource Use 8 1 2
and Cost Study
Inventory Tool--Health
Department.
Recipient-Led Evaluation 51 1 8
Annual Report Template--
Year 3 Effectiveness
Brief.
Partner/Site-Level.................... CQM Partner Site-Level 15 1 1
Interview Guide.
TBC Partner Site-Level 8 1 1
Interview Guide.
MTM Partner Site-Level 7 1 1
Interview Guide.
CCL Partner Site-Level 15 1 1
Informant Interview
Guide.
Cost Study Resource Use 17 1 2
and Cost Inventory
Tool--Partner/Site
Level.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2020-10409 Filed 5-14-20; 8:45 am]
BILLING CODE 4163-18-P